- $2.34bn
- $2.34bn
- $12.80m
Ekso Bionics Holdings Inc expected to post a loss of 31 cents a share - Earnings Preview
Brief: Ekso Bionics Reports Fourth Quarter And Year End 2022 Results
Ekso rises on deal to buy Parker-Hannifin unit
Brief: Ekso Bionics Announces Acquisition Of Human Motion, Control Business Unit Including Indego Product Line From Parker Hannifin Corp
Ekso Bionics Holdings Inc reports results for the quarter ended in September - Earnings Summary
Ekso Bionics Holdings Inc expected to post a loss of 24 cents a share - Earnings Preview
Brief: Ekso Bionics Holdings Inc Board Of Directors Approved Jerome Wong As Chief Financial Officer On Oct. 26
Ekso Bionics Holdings Inc expected to post a loss of 24 cents a share - Earnings Preview
Brief: Ekso Bionics Says Q2 Revenue Rose 57% To $3.5 Million
Ekso Bionics Holdings Inc reports results for the quarter ended in June - Earnings Summary
Ekso Bionics Holdings Inc expected to post a loss of 24 cents a share - Earnings Preview
Ekso Bionics climbs on FDA nod for use of robotic exoskeleton on MS patients
Brief: Ekso Bionics Receives FDA Clearance To Market Its Eksonr Robotic Exoskeleton For Use With Multiple Sclerosis Patients
Brief: Ekso Bionics Appoints Jerome Wong Interim Chief Financial Officer
Germany's Ottobock delays IPO due to market turmoil
Ekso Bionics Holdings Inc reports results for the quarter ended in March - Earnings Summary
Brief: Ekso Bionics Reports First Quarter 2022 Results
Ekso Bionics Holdings Inc expected to post a loss of 41 cents a share - Earnings Preview
Ekso Bionics Holdings Inc reports results for the quarter ended in December - Earnings Summary